FREE BONUS REPORTS: When you buy below report as a 5-user license, you may pick 3 additional cancer reports for free from this list
(Minumum Value: 5,850 EUR) OR When you buy below report as a unlimited license, you may pick 6 additional cancer reports for free from this list
(MinimumValue: 11,700 EUR)
Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created Cutting Edge Information’s new report, "Oncology Market Forecast to 2013," explores the fiercely competitive oncology market in a way that no other available forecast can match. Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide. Give your brand team all the oncology data it needs to make critical product decisions! Key Questions This Report Will Answer: - Which drugs will make the most money in the next five years?
- Which drug classes are poised for exponential growth?
- Whose portfolio will allow them to jump out in front of the oncology market?
The report profiles more than 130 Oncology Products and includes Oncology Portfolio Profiles for the following major companies: - Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Celgene
- Eli Lilly
- GlaxoSmithKline
- ImClone
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Schering-Plough
This report comes only at two price points: - 5-user license - $16,300.00 USD
- Unlimited license - $32,600.00 USD
Table of Contents Download TOC for the report Oncology Market Forecast to 2013 in PDF
|
